Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Gynecologic 2Genitourinary 2Gastrointestinal 2

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 109Leukemia, Myeloid, Acute 102Leukemia 97Myelodysplastic Syndromes 87Precursor Cell Lymphoblastic Leukemia-Lymphoma 74Lymphoma, Non-Hodgkin 71Lymphoma 71Multiple Myeloma 70Hodgkin Disease 68Lymphoma, Mantle-Cell 53Lymphoma, Follicular 51Lymphoma, Large B-Cell, Diffuse 50Leukemia, Myelogenous, Chronic, BCR-ABL Positive 45Lymphoma, B-Cell, Marginal Zone 44Myeloproliferative Disorders 43Congenital Abnormalities 41Burkitt Lymphoma 37Leukemia, Myelomonocytic, Chronic 36Waldenstrom Macroglobulinemia 32Leukemia, Myeloid, Accelerated Phase 32Primary Myelofibrosis 31Melanoma 31Lymphoma, Large-Cell, Immunoblastic 31Leukemia, Myeloid, Chronic-Phase 31Blast Crisis 28Recurrence 27Neoplasms, Plasma Cell 25Hematologic Neoplasms 24Lymphoma, T-Cell, Cutaneous 23Dendritic Cell Sarcoma, Interdigitating 23

Interventions

pembrolizumab 2fludarabine phosphate 2fludarabine 2aldesleukin 2Cyclophosphamide 2rocakinogene sifuplasmid 1durvalumab 1VGX-3100 1Surveys and Questionnaires 1Sildenafil Citrate 1Paclitaxel 1MEDI0457 1Interleukin-2 1Immunoglobulin G 1Ifosfamide 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Fentanyl 1Disulfides 1Cisplatin 1Alprostadil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Penile Neoplasms × fludarabine phosphate × Clear all
NCT01585428 2018-03-07

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
29 enrolled 12 charts
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Papillomavirus Infections

NCT02280811 2017-09-06

T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
12 enrolled 19 charts
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Neoplasm Metastasis, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡